C. S. McFarlane

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-<i>t</i>-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor

John W. Gillard, A W Ford‐Hutchinson, Chi-Chung Chan et al. · Canadian Journal of Physiology and Pharmacology · 1989 · 328 citations

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist

Thomas R. Jones, Robert Zamboni, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1989 · 270 citations

Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄receptor antagonist

Thomas R. Jones, Marc Labelle, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1995 · 251 citations

Inflammation, Molecular Pharmacology, Anti-inflammatory +14

Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(<i>t</i>-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor

Christine Brideau, Christine Chan, S. Charleson et al. · Canadian Journal of Physiology and Pharmacology · 1992 · 112 citations

Lipid Peroxidation, Whole Blood, Experimental Pharmacology +17

Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction

Marc Labelle, Michel Belley, Yves Gareau et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 100 citations

Inflammation, Anti-inflammatory, Functional Selectivity +7